The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
No relevant activity of olaratumab in patient-derived soft tissue sarcoma xenografts selected for expression of platelet-derived growth factor receptor a.
 
Jasmien Cornillie
No Relationships to Disclose
 
Britt Van Renterghem
No Relationships to Disclose
 
Nathalie Van Winkel
No Relationships to Disclose
 
Jasmien Wellens
No Relationships to Disclose
 
Yemarshet Gebreyohannes
No Relationships to Disclose
 
Maria Debiec-Rychter
No Relationships to Disclose
 
Raf Sciot
No Relationships to Disclose
 
Daphne Hompes
No Relationships to Disclose
 
Agnieszka Wozniak
No Relationships to Disclose
 
Patrick Schoffski
Consulting or Advisory Role - Adaptimmune (Inst); Blueprint Medicines (Inst); Deciphera (Inst); Eisai (Inst); Ellipses Pharma (Inst); Genmab (Inst); Intellisphere (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Plexxikon (Inst); SERVIER (Inst); Transgene (Inst)
Research Funding - Blueprint Medicines (Inst); Boehringer Ingelheim (Inst); CoBioRes NV (Inst); Eisai (Inst); Exelixis (Inst); G1 Therapeutics (Inst); Lilly (Inst); Novartis (Inst); PharmaMar (Inst); Plexxikon (Inst)